Annual Cash & Cash Equivalents
$54.90 M
+$22.23 M+68.02%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual cash & cash equivalents is currently $54.90 million, with the most recent change of +$22.23 million (+68.02%) on 31 December 2023. During the last 3 years, it has fallen by -$38.19 million (-41.03%). CRNX annual cash & cash equivalents is now -72.65% below its all-time high of $200.69 million, reached on 31 December 2021.CRNX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$317.27 M
+$15.11 M+5.00%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly cash and cash equivalents is currently $317.27 million, with the most recent change of +$15.11 million (+5.00%) on 30 September 2024. Over the past year, it has increased by +$174.47 million (+122.18%). CRNX quarterly cash and cash equivalents is now -19.87% below its all-time high of $395.92 million, reached on 31 March 2024.CRNX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.0% | +122.2% |
| 3 y3 years | -41.0% | +96.4% |
| 5 y5 years | +22.1% | +376.5% |
CRNX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.7% | +68.0% | -19.9% | +926.4% |
| 5 y | 5 years | -72.7% | +68.0% | -19.9% | +926.4% |
| alltime | all time | -72.7% | +351.8% | -19.9% | +2135.6% |
Crinetics Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $317.27 M(+5.0%) |
| June 2024 | - | $302.16 M(-23.7%) |
| Mar 2024 | - | $395.92 M(+621.2%) |
| Dec 2023 | $54.90 M(+68.0%) | $54.90 M(-61.6%) |
| Sept 2023 | - | $142.79 M(+261.0%) |
| June 2023 | - | $39.55 M(-4.0%) |
| Mar 2023 | - | $41.19 M(+26.1%) |
| Dec 2022 | $32.67 M(-83.7%) | $32.67 M(+5.7%) |
| Sept 2022 | - | $30.91 M(-50.4%) |
| June 2022 | - | $62.29 M(-57.2%) |
| Mar 2022 | - | $145.55 M(-27.5%) |
| Dec 2021 | $200.69 M | $200.69 M(+24.2%) |
| Sept 2021 | - | $161.54 M(-9.6%) |
| June 2021 | - | $178.77 M(+69.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $105.58 M(+13.4%) |
| Dec 2020 | $93.09 M(+130.8%) | $93.09 M(-21.0%) |
| Sept 2020 | - | $117.82 M(-26.7%) |
| June 2020 | - | $160.81 M(+215.8%) |
| Mar 2020 | - | $50.92 M(+26.3%) |
| Dec 2019 | $40.33 M(-10.3%) | $40.33 M(-39.4%) |
| Sept 2019 | - | $66.58 M(+11.5%) |
| June 2019 | - | $59.72 M(-5.0%) |
| Mar 2019 | - | $62.83 M(+39.7%) |
| Dec 2018 | $44.97 M(+216.9%) | $44.97 M(-73.5%) |
| Sept 2018 | - | $169.65 M(+148.0%) |
| June 2018 | - | $68.41 M(-7.2%) |
| Mar 2018 | - | $73.74 M(+419.6%) |
| Dec 2017 | $14.19 M(+16.8%) | $14.19 M |
| Dec 2016 | $12.15 M | - |
FAQ
- What is Crinetics Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Crinetics Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Crinetics Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of CRNX is $54.90 M
What is the all time high annual cash & cash equivalents for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual cash & cash equivalents is $200.69 M
What is Crinetics Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, CRNX annual cash & cash equivalents has changed by +$22.23 M (+68.02%)
What is Crinetics Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CRNX is $317.27 M
What is the all time high quarterly cash and cash equivalents for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly cash and cash equivalents is $395.92 M
What is Crinetics Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, CRNX quarterly cash and cash equivalents has changed by +$174.47 M (+122.18%)